from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2239c/-

LFCtreatmentdescriptionclass of inhibitor

0.174

Amikacinug/mL Amikacintranslation

-0.168

Cap5-10ug/mL Capreomycintranslation

0.167

Rox10-50 ug/mL Roxithromycintranslation

0.800

SM2-5 ug/mL Streptomycintranslation

0.109

Tet5-10 ug/mL Tetracyclinetranslation

-1.170

Rif0.2-5ug/mL Rifampicintranscription

-0.360

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.146

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.751

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.936

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.819

Clofazimine10-13 ug/mL Clofaziminerespiration

0.498

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.702

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.055

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.248

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.018

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.608

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.781

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.256

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.353

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.610

KCN5-20 ug/mL Potassium cyaniderespiration

0.149

NaN30.2-2 mM Sodium aziderespiration

1.033

Nigericin50 uM Nigericinrespiration

-0.847

TRC10-150 ug/mL Triclosanrespiration

-0.805

TRZ10-25 ug/mL Thioridazinerespiration

-1.099

Valinomycin0.5-10 uM Valinomycinrespiration

0.474

ZnSO42 mM ZnSO4respiration

0.234

menadione6-10 ug/mL Menadionerespiration

-0.561

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.299

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.366

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.300

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.345

NRP_1Non-replicating persistence stage 1dosRassociated

0.891

Amp0.2mg/mL AmpicillincellWall

0.271

Cephalexin20-100 ug/mL CephalexincellWall

0.375

Cerulenin0.32-5 ug/mL CerulenincellWall

0.589

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.446

EMB10-20 ug/mL EthambutolcellWall

0.843

Eta12-40 ug/mL EthionamidecellWall

1.078

INH0.2-0.4 ug/mL IsoniazidcellWall

0.692

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.396

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.048

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.742

BZA0.12 mg/mL BenzamidearomaticAmides

0.520

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.678

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.209

H2O24 mM hydrogen peroxideDNAdamaging

-0.067

Levo10 ug/mL LevofloxacinDNAdamaging

0.727

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.209

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.024

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.431

UVUV-irradiationDNAdamaging

-1.492

ARP41-4 ug/mL Antitubercular compound ARP4?

0.148

Antimycin12.5-50 ug/mL Antimycin A?

0.275

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.325

PA_110-50 ug/mL Antitubercular compound PA-1?

0.347

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.208

PA8240.2-2 ug/mL PA-824?

-0.308

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.081

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.191

Verapamil50 uM Verapamil?

0.014

mercaptoethanol2 mM 2-Mercaptoethanol?

0.001

methoxatin10-20 ug/mL Methoxatin?